Cargando…
Treatment needs and expectations for Fabry disease in France: development of a new Patient Needs Questionnaire
BACKGROUND: Fabry disease (FD) is a rare, X-linked, inherited lysosomal disease caused by absent or reduced α-galactosidase A activity. Due to the heterogeneity of disease presentation and progression, generic patient-reported outcome (PRO) tools do not provide accurate insight into patients’ daily...
Autores principales: | Noël, Esther, Dussol, Bertrand, Lacombe, Didier, Bedreddine, Najya, Fouilhoux, Alain, Ronco, Pierre, Genevaz, Delphine, Bekri, Soumeya, Hagège, Albert, Dupuis-Siméon, Frédérique, Derrien Ansquer, Valérie, Germain, Dominique P., Lidove, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894302/ https://www.ncbi.nlm.nih.gov/pubmed/31801581 http://dx.doi.org/10.1186/s13023-019-1254-7 |
Ejemplares similares
-
Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry Disease
por: Mauhin, Wladimir, et al.
Publicado: (2022) -
Understanding the challenges, unmet needs, and expectations of mucopolysaccharidoses I, II and VI patients and their caregivers in France: a survey study
por: Guffon, Nathalie, et al.
Publicado: (2022) -
Parsing Fabry Disease Metabolic Plasticity Using Metabolomics
por: Ducatez, Franklin, et al.
Publicado: (2021) -
Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients
por: Germain, Dominique P., et al.
Publicado: (2019) -
A Proteomics-Based Analysis Reveals Predictive Biological Patterns in Fabry Disease
por: Tebani, Abdellah, et al.
Publicado: (2020)